Xiaobei Mao
Overview
Explore the profile of Xiaobei Mao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Mao X, Xu Y, Li L, Geng J, Dai T, et al.
Phytother Res
. 2024 Jan;
38(3):1313-1328.
PMID: 38194947
5-Fluorouracil is a commonly used chemotherapy drug for colorectal cancer. Resistance to 5-Fluorouracil remains a challenge. This research aimed to explore the mechanism of 5-Fluorouracil resistance in colorectal cancer. RT-qPCR...
2.
Chen Y, Han C, Huang Y, Liu C, Sheng S, Ji L, et al.
Eur J Cancer Prev
. 2022 Jan;
31(5):430-441.
PMID: 34991112
Background: Second primary cancer (SPC) after primary colorectal cancer (CRC), emerges as a novel challenge for cancer prevention with pronounced differences between female and male patients. Methods: This was a...
3.
Huang Y, Ji L, Zhu J, Mao X, Sheng S, Hao S, et al.
Cancer Med
. 2021 Oct;
10(23):8708-8719.
PMID: 34697912
Background: Some significant differences exist between the outcomes of left- and right-sided colon cancer patients. The presence of nodal metastases is a critical prognostic factor, especially in the absence of...
4.
Wang Y, Wu M, Lei Z, Huang M, Li Z, Wang L, et al.
J Exp Clin Cancer Res
. 2018 Nov;
37(1):292.
PMID: 30486864
Background: Transcription factor forkhead box M1 (FOXM1) is a crucial regulator in colorectal cancer (CRC) progression. However, the regulatory mechanisms causing dysregulation of FOXM1 in CRC remain unclear. Methods: Dual-luciferase...
5.
Xie T, Geng J, Wang Y, Wang L, Huang M, Chen J, et al.
Oncotarget
. 2017 Jan;
8(5):8574-8589.
PMID: 28051999
5-Fluorouracil (5-FU) is the most commonly used chemotherapeutic agent for colorectal cancer (CRC). However, frequently occurred 5-FU resistance poses a great challenge in the clinic. Elucidating the underlying mechanisms and...
6.
Liu X, Xie T, Mao X, Xue L, Chu X, Chen L
Cell Physiol Biochem
. 2016 Jul;
39(2):617-29.
PMID: 27415661
Background/aims: Previously, we have shown that microRNA (miR)-149 suppresses the migration and invasion of colorectal cancer (CRC) cells by targeting forkhead box transcription factor (FOXM1). However, the roles of miR-149...
7.
Yang D, Dai T, Xue L, Liu X, Wu B, Geng J, et al.
Int J Clin Exp Pathol
. 2016 Jan;
8(10):13051-8.
PMID: 26722500
Previous studies have shown that chemokine receptor CXCR7 plays critical roles in tumor development. However, the clinicopathological and prognostic significance of CXCR7 in colorectal carcinoma (CRC) has not been fully...
8.
Xu K, Liu X, Mao X, Xue L, Wang R, Chen L, et al.
Cell Physiol Biochem
. 2015 Jan;
35(2):499-515.
PMID: 25613903
Background/aims: The aim of this study is to investigate the clinicopathological and prognostic values of miR-149 expression and its roles in colorectal cancer (CRC) progression. Methods: qRT-PCR was performed to...
9.
Wang J, Zhang Y, Xu K, Mao X, Xue L, Liu X, et al.
PLoS One
. 2014 Mar;
9(3):e90804.
PMID: 24614869
Epigenetic mechanisms play a key role in non-targeted effects of radiation. The purpose of this study was to investigate global hypomethylation and promoter hypermethylation of particular genes induced by low...
10.
Wang J, Mao X, Zhang Y, Xue L, Liu X, Geng J, et al.
Nan Fang Yi Ke Da Xue Xue Bao
. 2014 Mar;
34(2):228-31.
PMID: 24589602
Objective: To study the methylation changes in promoter CpG islands induced by low-dose X-ray radiation (LDR). Methods: Twenty male BALB/c mice were randomly divided into control and fractionated radiation group...